Synovial Fibroblast 3.1: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 1 of 2) - Dataset (ID:20234)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2159 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 4 | IL2-Ra | 42.0 | 75 | |
RA2159 | Poly(I:C) | 2 | ug/mL | 4 | IL2-Ra | 32.0 | 84 | ||||
N2645 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 4 | IL2-Ra | 22.0 | 69 | |
N2645 | Poly(I:C) | 2 | ug/mL | 4 | IL2-Ra | 23.0 | 73 | ||||
RA2708 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 4 | IL2-Ra | 22.5 | 56 | |
RA2708 | Poly(I:C) | 2 | ug/mL | 4 | IL2-Ra | 21.0 | 49 | ||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 4 | IL2-Ra | 87.0 | 66 | |
RA2159 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 4 | IL2-Ra | 67.0 | 69 | |
N2645 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 4 | IL2-Ra | 35.0 | 71 | |
N2645 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 4 | IL2-Ra | 28.0 | 68 | |
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 4 | IL2-Ra | 34.0 | 72 | |
RA2708 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 4 | IL2-Ra | 31.0 | 73 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 4 | IL2-Ra | 71.0 | 66 | |
RA2159 | IL-1 alpha | 100 | ng/mL | 4 | IL2-Ra | 71.0 | 45 | ||||
N2645 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 4 | IL2-Ra | 33.0 | 57 | |
N2645 | IL-1 alpha | 100 | ng/mL | 4 | IL2-Ra | 39.5 | 54 | ||||
RA2708 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 4 | IL2-Ra | 26.0 | 47 | |
RA2708 | IL-1 alpha | 100 | ng/mL | 4 | IL2-Ra | 26.5 | 54 | ||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 4 | IL2-Ra | 54.0 | 71 | |
RA2159 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 4 | IL2-Ra | 39.0 | 66 | |
N2645 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 4 | IL2-Ra | 25.5 | 64 | |
N2645 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 4 | IL2-Ra | 22.0 | 74 | |
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 4 | IL2-Ra | 19.0 | 69 | |
RA2708 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 4 | IL2-Ra | 23.0 | 63 | |
RA2159 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 4 | IL2-Ra | 62.0 | 39 |